Dermatology · Redding, CA
NPI
1144288523
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2701 Old Eureka Way, Suite 2a
Redding, CA, 96001
Phone (530) 246-0236
Groups this clinician bills Medicare through
Medicare paid, 2024
$536K
10,186 services
Medicare patients, 2024
1,028
Average age 78
Drug cost, 2024
$1.8M
1,590 prescriptions
Company payments, 2024
$28.07
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ronald E Reece was code 17003 (destruction skin lesion), 3,210 times for 537 patients. In total Ronald E Reece billed 10,186 services in 95 codes, and Medicare paid $536K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-08-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 3,210 | 537 | $5.17 | $17K |
| 99213 Office E&M - Established | Office | 1,652 | 820 | $66.54 | $110K |
| 17000 Destruction Skin Lesion | Office | 885 | 624 | $38.13 | $34K |
| 95044 Test - Miscellaneous | Office | 880 | 11 | $4.10 | $3,605 |
| 96910 Skin | Office | 664 | 21 | $99.41 | $66K |
| 17110 Destruction Skin Lesion | Office | 350 | 291 | $78.74 | $28K |
| 11104 Skin Biopsy | Office | 282 | 230 | $79.58 | $22K |
| 99214 Office E&M - Established | Office | 234 | 158 | $92.41 | $22K |
| 29581 Musculoskeletal | Office | 218 | 38 | $92.96 | $20K |
| 99212 Office E&M - Established | Office | 192 | 163 | $40.54 | $7,784 |
| J7308 Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 114 | 57 | $306.28 | $35K |
| 99203 Office E&M - New | Office | 114 | 114 | $74.32 | $8,472 |
| 96574 Skin | Office | 112 | 56 | $218.11 | $24K |
| 17004 Destruction Skin Lesion | Office | 111 | 87 | $127.58 | $14K |
| 11105 Skin Biopsy | Office | 80 | 51 | $45.70 | $3,656 |
By year: 2022 $576K for 10,024 services; 2023 $604K for 11,126 services; 2024 $536K for 10,186 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87101 General Laboratory | 67 | 62 | $7.56 | $506 |
| 87220 General Laboratory | 33 | 30 | $4.18 | $138 |
Medicare prescription drug claims, 2024
In 2024, the drug Ronald E Reece prescribed most often to Medicare patients was Ketoconazole, with 223 prescriptions and refills. In total Ronald E Reece wrote 1,590 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 223 | 225 | 79 | $2,981 |
| Triamcinolone Acetonide Generic | 181 | 194 | 99 | $1,264 |
| Doxycycline Monohydrate Generic | 112 | 128 | 70 | $2,247 |
| Otezla Apremilast | 75 | 90 | 11 | $425K |
| Dupixent Syringe Dupilumab | 73 | 79 | Under 11 | $300K |
| Imiquimod Generic | 65 | 97 | 54 | $1,869 |
| Clobetasol Propionate Generic | 61 | 64 | 38 | $4,267 |
| Doxycycline Hyclate Generic | 59 | 67 | 11 | $2,243 |
| Fluocinonide Generic | 58 | 74 | 25 | $3,652 |
| Mupirocin Generic | 54 | 54 | 41 | $276 |
| Fluorouracil Generic | 50 | 50 | 41 | $3,601 |
| Cephalexin Generic | 46 | 46 | 34 | $121 |
| Ciclopirox Ciclopirox Olamine | 40 | 47 | 28 | $848 |
| Tacrolimus Generic | 37 | 37 | 18 | $6,811 |
| Valacyclovir Valacyclovir Hcl | 33 | 43 | 23 | $914 |
Brand drugs: 244 claims; generic drugs: 1,346 claims; opioid claims: 28.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Ronald E Reece $28.07 ($28.07 in general payments such as food, travel and fees) from 1 company. The largest payer was CVRx, Inc. with $28.07.
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. CVRX | 1 | $28.07 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.